Benefits of TIPS for Patients With Large Ascites Preceding Recurrent or Refractory ascites: A Multicenter Cohort Study
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.16948 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Yifu Xia und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Ascites, Portasystemic Shunt, Transjugular Intrahepatic. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Science Fund for Distinguished Young Scholars of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background and Aim Patients with recurrent or refractory ascites can benefit from transjugular intrahepatic portosystemic shunt (TIPS). However, the value of TIPS for patients with large ascites remains unclear.
Methods
This retrospective multicenter study included patients who underwent TIPS or medicine plus large‐volume paracentesis (medicine + LVP) for ascites between January 2014 and December 2022 at five centers. The primary endpoint was recurrence or worsening of ascites. The secondary endpoints were liver‐related death, all‐cause hemorrhage, overt hepatic encephalopathy (OHE), and shunt dysfunction.
Results
Overall, 724 patients were evaluated, including 373 patients with large ascites preceding recurrent or refractory ascites received TIPS (the LA‐TIPS group), 282 patients with recurrent and refractory ascites received TIPS (the RA‐TIPS group), and 69 patients with large ascites preceding recurrent or refractory ascites received medicine + LVP (the LA‐M group). Patients in the LA‐TIPS group had significantly lower incidences of recurrence or worsening of ascites (37.4% vs. 45.3%, p < 0.001), liver‐related death (44.8% vs. 62.0%, p < 0.001), and OHE (47.3% vs. 60.3%, p < 0.001) than those in the RA‐TIPS group. Meanwhile, patients in the LA‐TIPS group had significantly lower incidences of recurrence or worsening of ascites (37.4% vs. 44.6%, p = 0.006) and hemorrhage (38.3% vs. 47.2%, p = 0.042), but a higher incidence of OHE (34.2% vs. 4.5%, p < 0.001) than those in the LA‐M group.
Conclusions
In terms of controlling ascites, the benefit of TIPS was greater in patients with large ascites preceding recurrent or refractory ascites, suggesting that TIPS might be considered in patients with large ascites before they progress to recurrent or refractory stages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
- Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi'an, Shaanxi, China.
- Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Department of Gastroenterology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
- Department of Infectious Diseases and Hepatology, The Second Hospital of Shandong University, Jinan, China.
ORCID-Profile: Jun Tie, Hao Wu, Yuzheng Zhuge, Xu Liu, Chengwei Tang, Chunqing Zhang
Förderung
- Science Fund for Distinguished Young Scholars of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Xia, Y., Tie, J., Wang, G., Wu, H., Zhuge, Y., Yuan, X., Huang, G., Li, Z., Liu, X., Chen, A., Zhang, L., Cai, Z., Tang, C., & Zhang, C. (2025). Benefits of TIPS for Patients With Large Ascites Preceding Recurrent or Refractory ascites: A Multicenter Cohort Study. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16948
Vancouver
Xia Y, Tie J, Wang G, Wu H, Zhuge Y, Yuan X, et al. Benefits of TIPS for Patients With Large Ascites Preceding Recurrent or Refractory ascites: A Multicenter Cohort Study. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16948
BibTeX
@article{Xia2025,
author = {Xia, Yifu and Tie, Jun and Wang, Guangchuan and Wu, Hao and Zhuge, Yuzheng and Yuan, Xulong and Huang, Guangjun and Li, Zhen and Liu, Xu and Chen, Anbang and Zhang, Linhao and Cai, Zihao and Tang, Chengwei and Zhang, Chunqing},
title = {Benefits of TIPS for Patients With Large Ascites Preceding Recurrent or Refractory ascites: A Multicenter Cohort Study},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.16948}
}
EUVIMED